Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes

H. IJspeert, GJ. Driessen, MJ. Moorhouse, NG. Hartwig, B. Wolska-Kusnierz, K. Kalwak, A. Pituch-Noworolska, I. Kondratenko, JM. van Montfrans, E. Mejstrikova, AC. Lankester, AW. Langerak, DC. van Gent, AP. Stubbs, JJ. van Dongen, M. van der Burg,

. 2014 ; 133 (4) : 1124-1133.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14063765

Grant support
NT13271 MZ0 CEP Register

BACKGROUND: V(D)J recombination takes place during lymphocyte development to generate a large repertoire of T- and B-cell receptors. Mutations in recombination-activating gene 1 (RAG1) and RAG2 result in loss or reduction of V(D)J recombination. It is known that different mutations in RAG genes vary in residual recombinase activity and give rise to a broad spectrum of clinical phenotypes. OBJECTIVE: We sought to study the immunologic mechanisms causing the clinical spectrum of RAG deficiency. METHODS: We included 22 patients with similar RAG1 mutations (c.519delT or c.368_369delAA) resulting in N-terminal truncated RAG1 protein with residual recombination activity but presenting with different clinical phenotypes. We studied precursor B-cell development, immunoglobulin and T-cell receptor repertoire formation, receptor editing, and B- and T-cell numbers. RESULTS: Clinically, patients were divided into 3 main categories: T(-)B(-) severe combined immunodeficiency, Omenn syndrome, and combined immunodeficiency. All patients showed a block in the precursor B-cell development, low B- and T-cell numbers, normal immunoglobulin gene use, limited B- and T-cell repertoires, and slightly impaired receptor editing. CONCLUSION: This study demonstrates that similar RAG mutations can result in similar immunobiological effects but different clinical phenotypes, indicating that the level of residual recombinase activity is not the only determinant for clinical outcome. We postulate a model in which the type and moment of antigenic pressure affect the clinical phenotypes of these patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14063765
003      
CZ-PrNML
005      
20190702102617.0
007      
ta
008      
140704s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jaci.2013.11.028 $2 doi
035    __
$a (PubMed)24418478
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a IJspeert, Hanna $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
245    10
$a Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes / $c H. IJspeert, GJ. Driessen, MJ. Moorhouse, NG. Hartwig, B. Wolska-Kusnierz, K. Kalwak, A. Pituch-Noworolska, I. Kondratenko, JM. van Montfrans, E. Mejstrikova, AC. Lankester, AW. Langerak, DC. van Gent, AP. Stubbs, JJ. van Dongen, M. van der Burg,
520    9_
$a BACKGROUND: V(D)J recombination takes place during lymphocyte development to generate a large repertoire of T- and B-cell receptors. Mutations in recombination-activating gene 1 (RAG1) and RAG2 result in loss or reduction of V(D)J recombination. It is known that different mutations in RAG genes vary in residual recombinase activity and give rise to a broad spectrum of clinical phenotypes. OBJECTIVE: We sought to study the immunologic mechanisms causing the clinical spectrum of RAG deficiency. METHODS: We included 22 patients with similar RAG1 mutations (c.519delT or c.368_369delAA) resulting in N-terminal truncated RAG1 protein with residual recombination activity but presenting with different clinical phenotypes. We studied precursor B-cell development, immunoglobulin and T-cell receptor repertoire formation, receptor editing, and B- and T-cell numbers. RESULTS: Clinically, patients were divided into 3 main categories: T(-)B(-) severe combined immunodeficiency, Omenn syndrome, and combined immunodeficiency. All patients showed a block in the precursor B-cell development, low B- and T-cell numbers, normal immunoglobulin gene use, limited B- and T-cell repertoires, and slightly impaired receptor editing. CONCLUSION: This study demonstrates that similar RAG mutations can result in similar immunobiological effects but different clinical phenotypes, indicating that the level of residual recombinase activity is not the only determinant for clinical outcome. We postulate a model in which the type and moment of antigenic pressure affect the clinical phenotypes of these patients.
650    _2
$a B-lymfocyty $x imunologie $x metabolismus $7 D001402
650    _2
$a předškolní dítě $7 D002675
650    _2
$a hypervariabilní oblasti $x genetika $7 D022801
650    _2
$a exprese genu $7 D015870
650    12
$a genetické asociační studie $7 D056726
650    _2
$a genotyp $7 D005838
650    _2
$a homeodoménové proteiny $x genetika $x metabolismus $7 D018398
650    _2
$a lidé $7 D006801
650    _2
$a těžké řetězce imunoglobulinů $x genetika $7 D007143
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a počet lymfocytů $7 D018655
650    12
$a mutace $7 D009154
650    12
$a fenotyp $7 D010641
650    _2
$a těžká kombinovaná imunodeficience $x diagnóza $x genetika $x imunologie $x metabolismus $7 D016511
650    _2
$a T-lymfocyty $x imunologie $x metabolismus $7 D013601
650    _2
$a V(D)J rekombinace $7 D060152
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Driessen, Gertjan J $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a Moorhouse, Michael J $u Department of Blood Cell Research, Stichting Sanquin Bloedvoorziening, Amsterdam, The Netherlands.
700    1_
$a Hartwig, Nico G $u Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a Wolska-Kusnierz, Beata $u Department of Immunology, Children's Memorial Health Institute, Warsaw, Poland.
700    1_
$a Kalwak, Krzysztof $u Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
700    1_
$a Pituch-Noworolska, Anna $u Department of Clinical Immunology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
700    1_
$a Kondratenko, Irina $u Department of Clinical Immunology, Russian State Children's Hospital, Moscow, Russia.
700    1_
$a van Montfrans, Joris M $u Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht and Wilhelmina Children's Hospital, Utrecht, The Netherlands.
700    1_
$a Mejstříková, Ester, $u Department of Pediatric Hematology and Oncology, Teaching Hospital Motol and 2nd Medical School, Charles University, Prague, Czech Republic. $d 1977- $7 xx0105223
700    1_
$a Lankester, Arjan C $u Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
700    1_
$a Langerak, Anton W $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a van Gent, Dik C $u Department of Cell Biology and Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a Stubbs, Andrew P $u Department of Bioinformatics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a van Dongen, Jacques J M $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a van der Burg, Mirjam $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: m.vanderburg@erasmusmc.nl.
773    0_
$w MED00002505 $t The Journal of allergy and clinical immunology $x 1097-6825 $g Roč. 133, č. 4 (2014), s. 1124-1133
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24418478 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20190702102806 $b ABA008
999    __
$a ok $b bmc $g 1031249 $s 862497
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 133 $c 4 $d 1124-1133 $i 1097-6825 $m Journal of allergy and clinical immunology $n J Allergy Clin Immunol $x MED00002505
GRA    __
$a NT13271 $p MZ0
LZP    __
$a Pubmed-20140704

Find record

Citation metrics

Archiving options